5513 related articles for article (PubMed ID: 3518473)
1. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes.
Gown AM; Vogel AM; Hoak D; Gough F; McNutt MA
Am J Pathol; 1986 May; 123(2):195-203. PubMed ID: 3518473
[TBL] [Abstract][Full Text] [Related]
2. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
Steuhl KP; Rohrbach JM; Knorr M
Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
[TBL] [Abstract][Full Text] [Related]
3. Antibody HMB-45 identifies the cells of blue nevi. An immunohistochemical study on paraffin sections.
Sun J; Morton TH; Gown AM
Am J Surg Pathol; 1990 Aug; 14(8):748-51. PubMed ID: 2378395
[TBL] [Abstract][Full Text] [Related]
4. Immunoperoxidase technique modified by counterstain with azure B as a diagnostic aid in evaluating heavily pigmented melanocytic neoplasms.
Kamino H; Tam ST
J Cutan Pathol; 1991 Dec; 18(6):436-9. PubMed ID: 1723081
[TBL] [Abstract][Full Text] [Related]
5. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
6. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation.
Skelton HG; Smith KJ; Barrett TL; Lupton GP; Graham JH
Am J Dermatopathol; 1991 Dec; 13(6):543-50. PubMed ID: 1725245
[TBL] [Abstract][Full Text] [Related]
7. SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions.
Trefzer U; Rietz N; Chen Y; Audring H; Herberth G; Siegel P; Reinke S; Königer P; Wu S; Ma J; Liu Y; Wang H; Sterry W; Guo Y
Arch Dermatol Res; 2000 Dec; 292(12):583-9. PubMed ID: 11214818
[TBL] [Abstract][Full Text] [Related]
8. A simple immunochemical technique for distinguishing melanocytes and melanophages in paraffin-embedded tissue.
Fleming MG; Bergfeld WF
J Cutan Pathol; 1990 Apr; 17(2):77-81. PubMed ID: 1692575
[TBL] [Abstract][Full Text] [Related]
9. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
Santucci M; Urso C; Giannini A; Bondi R
Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
[TBL] [Abstract][Full Text] [Related]
10. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors.
Steuhl KP; Rohrbach JM; Knorr M; Thiel HJ
Ophthalmology; 1993 Feb; 100(2):208-15. PubMed ID: 8437829
[TBL] [Abstract][Full Text] [Related]
11. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma.
Sexton M; Sexton CW
Arch Pathol Lab Med; 1991 Feb; 115(2):122-6. PubMed ID: 1992976
[TBL] [Abstract][Full Text] [Related]
12. HMB-45 immunohistochemical staining of conjunctival melanocytic lesions.
McDonnell JM; Sun YY; Wagner D
Ophthalmology; 1991 Apr; 98(4):453-8. PubMed ID: 1711186
[TBL] [Abstract][Full Text] [Related]
13. Melanocytes express 3G5 surface antigen.
Fiedler E; Nayak RC; Marsch WCh; Helmbold P
Am J Dermatopathol; 2004 Jun; 26(3):200-4. PubMed ID: 15166506
[TBL] [Abstract][Full Text] [Related]
14. Melanocytes of a melanocytic nevus in a lymph node from a patient with a primary cutaneous melanoma associated with a small congenital nevus.
Hruban RH; Eckert F; Baricević B
Am J Dermatopathol; 1990 Aug; 12(4):402-7. PubMed ID: 2203272
[TBL] [Abstract][Full Text] [Related]
15. [HMB 45 positive balloon cells in combined nevi].
Laaff H; Kühnl-Petzoldt C
Hautarzt; 1992 Sep; 43(9):566-8. PubMed ID: 1399602
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies selected to discriminate between malignant melanomas and nevocellular nevi.
Ruiter DJ; Dingjan GM; Steijlen PM; van Beveren-Hooyer M; de Graaff-Reitsma C; Bergman W; van Muijen GN; Warnaar SO
J Invest Dermatol; 1985 Jul; 85(1):4-8. PubMed ID: 3891875
[TBL] [Abstract][Full Text] [Related]
17. Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections.
Imam A; Mitchell MS; Modlin RL; Taylor CR; Kempf RA; Kan-Mitchell J
J Invest Dermatol; 1986 Feb; 86(2):145-8. PubMed ID: 3528308
[TBL] [Abstract][Full Text] [Related]
18. HMB-45 recognizes stimulated melanocytes.
Smoller BR; McNutt NS; Hsu A
J Cutan Pathol; 1989 Apr; 16(2):49-53. PubMed ID: 2668355
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of melanocytic nevi from malignant melanomas in palms, soles, and nail beds solely by signs in the cornified layer of the epidermis.
Kerl H; Trau H; Ackerman AB
Am J Dermatopathol; 1984; 6 Suppl():159-60. PubMed ID: 6528914
[No Abstract] [Full Text] [Related]
20. Evaluation of melanocytic neoplasms: application of a pan-melanoma antibody cocktail.
Orchard G
Br J Biomed Sci; 2002; 59(4):196-202. PubMed ID: 12572952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
